Q1 2024 Cigna Group Earnings Call Transcript
Key Points
- The Cigna Group reported strong financial results with total revenue of $57.3 billion and adjusted earnings per share of $6.47 for the first quarter.
- The company increased its guidance for full year adjusted earnings per share to at least $28.40, reflecting confidence in continued strong performance.
- Evernorth Health Services showed strong results, particularly in Pharmacy Benefit Services and Specialty Care, demonstrating growth and effective execution.
- The Cigna Group's focus on innovative solutions like EnCircleRx for Cardiodiabesity and biosimilars in specialty pharmaceuticals is driving greater access and affordability.
- The company's strategic investments in areas like accountable care, virtual, home-based, and behavioral care are showing positive progress and expansion.
- The Cigna Group recorded a shareholders' net loss of $277 million in the first quarter, primarily due to a noncash after-tax net realized investment loss of $1.8 billion related to a VillageMD impairment charge.
- There were disruptions in claim submissions and payments due to issues with Change Healthcare, impacting first quarter operations.
- The company experienced incremental operating expenses due to the Change Healthcare incident, which were reflected in the first quarter results.
- Despite strategic pricing actions to improve margins, the individual exchange business is tracking to end slightly below the target profit margin range of 4% to 6%.
- The Specialty and Care Services margin within Evernorth was down year-over-year, showing some variability and impacting the overall margin profile for the quarter.
Ladies and gentlemen, thank you for standing by for The Cigna Group's First Quarter 2024 Results Review. (Operator Instructions) As a reminder, ladies and gentlemen, this conference, including the Q&A session, is being recorded.
We'll begin by turning the conference over to Ralph Giacobbe. Please go ahead.
Good morning. Thank you for joining today's call. I'm Ralph Giacobbe, Senior Vice President of Investor Relations. With me on the line this morning are David Cordani, The Cigna Group's Chairman and Chief Executive Officer; Brian Evanko, Chief Financial Officer of The Cigna Group and President and Chief Executive Officer of Cigna Healthcare; and Eric Palmer, President and Chief Executive Officer of Evernorth Health Services.
In our remarks today, David and Brian will cover a number of topics, including our first quarter financial results and our updated financial outlook for 2024. Following their prepared remarks, David, Brian and Eric will be available for Q&A.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
